Your institution may have access to this item. Find your institution then sign in to continue.
Title
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Authors
Schmidt, Mary Lou; Lal, Ashutosh; Seeger, Robert C; Maris, John M; Shimada, Hiroyuki; O'Leary, Maura; Gerbing, Robert B; Matthay, Katherine K
Abstract
The long-term survival of children between age 12 and 24 months with stage 4 neuroblastoma and nonamplified MYCN (MYCN-NA) has not been defined previously.
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 27, p6474